MOL CARCINOGEN 润色咨询

MOLECULAR CARCINOGENESIS

出版年份：1988 年文章数：1469 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：3.2% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制<br>经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA<br>经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月 催稿不回 醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111862, encodeId=181a21118625e, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：请问最近审稿时间一般多久？投稿第二天就under review了，过了一个多月还没消息，给编辑发邮件也一周多没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Sat Jan 28 15:26:11 CST 2023, time=2023-01-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2137382, encodeId=fa7c213e382e4, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤研究;分子机制<br>经验分享：投过去快三个月了，一直都是under review,唉，也是感觉编辑部的外审速度快慢不一。催稿说是外审意见还没有完全回来，只能煎熬得等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9b6471268, createdName=ms6000002108689902, createdTime=Thu May 18 09:16:39 CST 2023, time=2023-05-18, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2089443, encodeId=bf24208944309, content=偏重的研究方向：肿瘤基础研究;肿瘤;分子机制<br>经验分享：2022.8.15 投稿； 2022.8.30返回一审意见-Major revision 两个审稿人一共提了七条意见吧大概；其中让补实验的有两条，我应该算完成了不到半条； 2022.9.13 返修； 2022.9.21 接收。 我自己这篇文章感觉其实内容还算蛮多，之前投过2个，一个小小cdd 俩星期未送外审被拒，一个cancer science 秒拒，建议转投这个杂志，投稿流程挺顺畅，审稿速度蛮快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b376540466, createdName=ms5000000426407939, createdTime=Wed Sep 21 00:07:41 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121995, encodeId=35032121995ca, content=审稿速度:1.0<br>偏重的研究方向：肿瘤基础研究;肿瘤<br>经验分享：五个figure，机制探索简单，但有回复实验。2022.12.20投稿，2023.1.12返修 major revision，给了60天。两个审稿人，每个人三个大的问题，主要是补一些数据，基本都补了。2023.3.8修回，2023.3.25接收。供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLtN0xODbla5nDe8Fgiaj3BwpB7FcMGmbXscXsuUpkYeQOiaaaFLsdVnec4QqrEEztWa9BGCOSyHBJQ/132, createdBy=05db2477999, createdName=124507bbm29(暂无昵称), createdTime=Mon Mar 27 00:37:33 CST 2023, time=2023-03-27, status=1, ipAttribution=北京)]
    2024-04-18 lijiwei.li_99476115 来自河南省

    大神们，这个杂志需要原始数据吗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制<br>经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA<br>经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月 催稿不回 醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111862, encodeId=181a21118625e, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：请问最近审稿时间一般多久？投稿第二天就under review了，过了一个多月还没消息，给编辑发邮件也一周多没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Sat Jan 28 15:26:11 CST 2023, time=2023-01-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2137382, encodeId=fa7c213e382e4, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤研究;分子机制<br>经验分享：投过去快三个月了，一直都是under review,唉，也是感觉编辑部的外审速度快慢不一。催稿说是外审意见还没有完全回来，只能煎熬得等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9b6471268, createdName=ms6000002108689902, createdTime=Thu May 18 09:16:39 CST 2023, time=2023-05-18, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2089443, encodeId=bf24208944309, content=偏重的研究方向：肿瘤基础研究;肿瘤;分子机制<br>经验分享：2022.8.15 投稿； 2022.8.30返回一审意见-Major revision 两个审稿人一共提了七条意见吧大概；其中让补实验的有两条，我应该算完成了不到半条； 2022.9.13 返修； 2022.9.21 接收。 我自己这篇文章感觉其实内容还算蛮多，之前投过2个，一个小小cdd 俩星期未送外审被拒，一个cancer science 秒拒，建议转投这个杂志，投稿流程挺顺畅，审稿速度蛮快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b376540466, createdName=ms5000000426407939, createdTime=Wed Sep 21 00:07:41 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121995, encodeId=35032121995ca, content=审稿速度:1.0<br>偏重的研究方向：肿瘤基础研究;肿瘤<br>经验分享：五个figure，机制探索简单，但有回复实验。2022.12.20投稿，2023.1.12返修 major revision，给了60天。两个审稿人，每个人三个大的问题，主要是补一些数据，基本都补了。2023.3.8修回，2023.3.25接收。供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLtN0xODbla5nDe8Fgiaj3BwpB7FcMGmbXscXsuUpkYeQOiaaaFLsdVnec4QqrEEztWa9BGCOSyHBJQ/132, createdBy=05db2477999, createdName=124507bbm29(暂无昵称), createdTime=Mon Mar 27 00:37:33 CST 2023, time=2023-03-27, status=1, ipAttribution=北京)]
    2024-03-28 ms1000001248507298 来自江苏

    偏重的研究方向：肿瘤;非编码RNA;分子机制
    经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制<br>经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA<br>经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月 催稿不回 醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111862, encodeId=181a21118625e, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：请问最近审稿时间一般多久？投稿第二天就under review了，过了一个多月还没消息，给编辑发邮件也一周多没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Sat Jan 28 15:26:11 CST 2023, time=2023-01-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2137382, encodeId=fa7c213e382e4, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤研究;分子机制<br>经验分享：投过去快三个月了，一直都是under review,唉，也是感觉编辑部的外审速度快慢不一。催稿说是外审意见还没有完全回来，只能煎熬得等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9b6471268, createdName=ms6000002108689902, createdTime=Thu May 18 09:16:39 CST 2023, time=2023-05-18, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2089443, encodeId=bf24208944309, content=偏重的研究方向：肿瘤基础研究;肿瘤;分子机制<br>经验分享：2022.8.15 投稿； 2022.8.30返回一审意见-Major revision 两个审稿人一共提了七条意见吧大概；其中让补实验的有两条，我应该算完成了不到半条； 2022.9.13 返修； 2022.9.21 接收。 我自己这篇文章感觉其实内容还算蛮多，之前投过2个，一个小小cdd 俩星期未送外审被拒，一个cancer science 秒拒，建议转投这个杂志，投稿流程挺顺畅，审稿速度蛮快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b376540466, createdName=ms5000000426407939, createdTime=Wed Sep 21 00:07:41 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121995, encodeId=35032121995ca, content=审稿速度:1.0<br>偏重的研究方向：肿瘤基础研究;肿瘤<br>经验分享：五个figure，机制探索简单，但有回复实验。2022.12.20投稿，2023.1.12返修 major revision，给了60天。两个审稿人，每个人三个大的问题，主要是补一些数据，基本都补了。2023.3.8修回，2023.3.25接收。供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLtN0xODbla5nDe8Fgiaj3BwpB7FcMGmbXscXsuUpkYeQOiaaaFLsdVnec4QqrEEztWa9BGCOSyHBJQ/132, createdBy=05db2477999, createdName=124507bbm29(暂无昵称), createdTime=Mon Mar 27 00:37:33 CST 2023, time=2023-03-27, status=1, ipAttribution=北京)]
    2024-04-08 ms5000001127810224 来自浙江省

    审稿速度:6.0
    偏重的研究方向：肿瘤
    经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制<br>经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA<br>经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月 催稿不回 醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111862, encodeId=181a21118625e, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：请问最近审稿时间一般多久？投稿第二天就under review了，过了一个多月还没消息，给编辑发邮件也一周多没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Sat Jan 28 15:26:11 CST 2023, time=2023-01-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2137382, encodeId=fa7c213e382e4, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤研究;分子机制<br>经验分享：投过去快三个月了，一直都是under review,唉，也是感觉编辑部的外审速度快慢不一。催稿说是外审意见还没有完全回来，只能煎熬得等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9b6471268, createdName=ms6000002108689902, createdTime=Thu May 18 09:16:39 CST 2023, time=2023-05-18, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2089443, encodeId=bf24208944309, content=偏重的研究方向：肿瘤基础研究;肿瘤;分子机制<br>经验分享：2022.8.15 投稿； 2022.8.30返回一审意见-Major revision 两个审稿人一共提了七条意见吧大概；其中让补实验的有两条，我应该算完成了不到半条； 2022.9.13 返修； 2022.9.21 接收。 我自己这篇文章感觉其实内容还算蛮多，之前投过2个，一个小小cdd 俩星期未送外审被拒，一个cancer science 秒拒，建议转投这个杂志，投稿流程挺顺畅，审稿速度蛮快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b376540466, createdName=ms5000000426407939, createdTime=Wed Sep 21 00:07:41 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121995, encodeId=35032121995ca, content=审稿速度:1.0<br>偏重的研究方向：肿瘤基础研究;肿瘤<br>经验分享：五个figure，机制探索简单，但有回复实验。2022.12.20投稿，2023.1.12返修 major revision，给了60天。两个审稿人，每个人三个大的问题，主要是补一些数据，基本都补了。2023.3.8修回，2023.3.25接收。供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLtN0xODbla5nDe8Fgiaj3BwpB7FcMGmbXscXsuUpkYeQOiaaaFLsdVnec4QqrEEztWa9BGCOSyHBJQ/132, createdBy=05db2477999, createdName=124507bbm29(暂无昵称), createdTime=Mon Mar 27 00:37:33 CST 2023, time=2023-03-27, status=1, ipAttribution=北京)]
    2023-04-06 ms7000001027936853 来自重庆

    偏重的研究方向：肿瘤;非编码RNA
    经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收

    6

    展开6条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制<br>经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA<br>经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月 催稿不回 醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111862, encodeId=181a21118625e, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：请问最近审稿时间一般多久？投稿第二天就under review了，过了一个多月还没消息，给编辑发邮件也一周多没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Sat Jan 28 15:26:11 CST 2023, time=2023-01-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2137382, encodeId=fa7c213e382e4, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤研究;分子机制<br>经验分享：投过去快三个月了，一直都是under review,唉，也是感觉编辑部的外审速度快慢不一。催稿说是外审意见还没有完全回来，只能煎熬得等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9b6471268, createdName=ms6000002108689902, createdTime=Thu May 18 09:16:39 CST 2023, time=2023-05-18, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2089443, encodeId=bf24208944309, content=偏重的研究方向：肿瘤基础研究;肿瘤;分子机制<br>经验分享：2022.8.15 投稿； 2022.8.30返回一审意见-Major revision 两个审稿人一共提了七条意见吧大概；其中让补实验的有两条，我应该算完成了不到半条； 2022.9.13 返修； 2022.9.21 接收。 我自己这篇文章感觉其实内容还算蛮多，之前投过2个，一个小小cdd 俩星期未送外审被拒，一个cancer science 秒拒，建议转投这个杂志，投稿流程挺顺畅，审稿速度蛮快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b376540466, createdName=ms5000000426407939, createdTime=Wed Sep 21 00:07:41 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121995, encodeId=35032121995ca, content=审稿速度:1.0<br>偏重的研究方向：肿瘤基础研究;肿瘤<br>经验分享：五个figure，机制探索简单，但有回复实验。2022.12.20投稿，2023.1.12返修 major revision，给了60天。两个审稿人，每个人三个大的问题，主要是补一些数据，基本都补了。2023.3.8修回，2023.3.25接收。供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLtN0xODbla5nDe8Fgiaj3BwpB7FcMGmbXscXsuUpkYeQOiaaaFLsdVnec4QqrEEztWa9BGCOSyHBJQ/132, createdBy=05db2477999, createdName=124507bbm29(暂无昵称), createdTime=Mon Mar 27 00:37:33 CST 2023, time=2023-03-27, status=1, ipAttribution=北京)]
    2023-03-28 ms7000000699329508 来自广东省

    想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题

    3

    展开3条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制<br>经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA<br>经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月 催稿不回 醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111862, encodeId=181a21118625e, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：请问最近审稿时间一般多久？投稿第二天就under review了，过了一个多月还没消息，给编辑发邮件也一周多没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Sat Jan 28 15:26:11 CST 2023, time=2023-01-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2137382, encodeId=fa7c213e382e4, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤研究;分子机制<br>经验分享：投过去快三个月了，一直都是under review,唉，也是感觉编辑部的外审速度快慢不一。催稿说是外审意见还没有完全回来，只能煎熬得等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9b6471268, createdName=ms6000002108689902, createdTime=Thu May 18 09:16:39 CST 2023, time=2023-05-18, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2089443, encodeId=bf24208944309, content=偏重的研究方向：肿瘤基础研究;肿瘤;分子机制<br>经验分享：2022.8.15 投稿； 2022.8.30返回一审意见-Major revision 两个审稿人一共提了七条意见吧大概；其中让补实验的有两条，我应该算完成了不到半条； 2022.9.13 返修； 2022.9.21 接收。 我自己这篇文章感觉其实内容还算蛮多，之前投过2个，一个小小cdd 俩星期未送外审被拒，一个cancer science 秒拒，建议转投这个杂志，投稿流程挺顺畅，审稿速度蛮快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b376540466, createdName=ms5000000426407939, createdTime=Wed Sep 21 00:07:41 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121995, encodeId=35032121995ca, content=审稿速度:1.0<br>偏重的研究方向：肿瘤基础研究;肿瘤<br>经验分享：五个figure，机制探索简单，但有回复实验。2022.12.20投稿，2023.1.12返修 major revision，给了60天。两个审稿人，每个人三个大的问题，主要是补一些数据，基本都补了。2023.3.8修回，2023.3.25接收。供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLtN0xODbla5nDe8Fgiaj3BwpB7FcMGmbXscXsuUpkYeQOiaaaFLsdVnec4QqrEEztWa9BGCOSyHBJQ/132, createdBy=05db2477999, createdName=124507bbm29(暂无昵称), createdTime=Mon Mar 27 00:37:33 CST 2023, time=2023-03-27, status=1, ipAttribution=北京)]
    2023-03-06 ms7000000359211492 来自浙江省

    二审三个月 催稿不回 醉了

    5

    展开5条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制<br>经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA<br>经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月 催稿不回 醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111862, encodeId=181a21118625e, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：请问最近审稿时间一般多久？投稿第二天就under review了，过了一个多月还没消息，给编辑发邮件也一周多没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Sat Jan 28 15:26:11 CST 2023, time=2023-01-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2137382, encodeId=fa7c213e382e4, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤研究;分子机制<br>经验分享：投过去快三个月了，一直都是under review,唉，也是感觉编辑部的外审速度快慢不一。催稿说是外审意见还没有完全回来，只能煎熬得等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9b6471268, createdName=ms6000002108689902, createdTime=Thu May 18 09:16:39 CST 2023, time=2023-05-18, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2089443, encodeId=bf24208944309, content=偏重的研究方向：肿瘤基础研究;肿瘤;分子机制<br>经验分享：2022.8.15 投稿； 2022.8.30返回一审意见-Major revision 两个审稿人一共提了七条意见吧大概；其中让补实验的有两条，我应该算完成了不到半条； 2022.9.13 返修； 2022.9.21 接收。 我自己这篇文章感觉其实内容还算蛮多，之前投过2个，一个小小cdd 俩星期未送外审被拒，一个cancer science 秒拒，建议转投这个杂志，投稿流程挺顺畅，审稿速度蛮快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b376540466, createdName=ms5000000426407939, createdTime=Wed Sep 21 00:07:41 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121995, encodeId=35032121995ca, content=审稿速度:1.0<br>偏重的研究方向：肿瘤基础研究;肿瘤<br>经验分享：五个figure，机制探索简单，但有回复实验。2022.12.20投稿，2023.1.12返修 major revision，给了60天。两个审稿人，每个人三个大的问题，主要是补一些数据，基本都补了。2023.3.8修回，2023.3.25接收。供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLtN0xODbla5nDe8Fgiaj3BwpB7FcMGmbXscXsuUpkYeQOiaaaFLsdVnec4QqrEEztWa9BGCOSyHBJQ/132, createdBy=05db2477999, createdName=124507bbm29(暂无昵称), createdTime=Mon Mar 27 00:37:33 CST 2023, time=2023-03-27, status=1, ipAttribution=北京)]
    2023-01-28 ms7000001027936853 来自重庆

    偏重的研究方向：肿瘤;分子机制
    经验分享：请问最近审稿时间一般多久？投稿第二天就under review了，过了一个多月还没消息，给编辑发邮件也一周多没有回复

    11

    展开11条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制<br>经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA<br>经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月 催稿不回 醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111862, encodeId=181a21118625e, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：请问最近审稿时间一般多久？投稿第二天就under review了，过了一个多月还没消息，给编辑发邮件也一周多没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Sat Jan 28 15:26:11 CST 2023, time=2023-01-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2137382, encodeId=fa7c213e382e4, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤研究;分子机制<br>经验分享：投过去快三个月了，一直都是under review,唉，也是感觉编辑部的外审速度快慢不一。催稿说是外审意见还没有完全回来，只能煎熬得等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9b6471268, createdName=ms6000002108689902, createdTime=Thu May 18 09:16:39 CST 2023, time=2023-05-18, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2089443, encodeId=bf24208944309, content=偏重的研究方向：肿瘤基础研究;肿瘤;分子机制<br>经验分享：2022.8.15 投稿； 2022.8.30返回一审意见-Major revision 两个审稿人一共提了七条意见吧大概；其中让补实验的有两条，我应该算完成了不到半条； 2022.9.13 返修； 2022.9.21 接收。 我自己这篇文章感觉其实内容还算蛮多，之前投过2个，一个小小cdd 俩星期未送外审被拒，一个cancer science 秒拒，建议转投这个杂志，投稿流程挺顺畅，审稿速度蛮快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b376540466, createdName=ms5000000426407939, createdTime=Wed Sep 21 00:07:41 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121995, encodeId=35032121995ca, content=审稿速度:1.0<br>偏重的研究方向：肿瘤基础研究;肿瘤<br>经验分享：五个figure，机制探索简单，但有回复实验。2022.12.20投稿，2023.1.12返修 major revision，给了60天。两个审稿人，每个人三个大的问题，主要是补一些数据，基本都补了。2023.3.8修回，2023.3.25接收。供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLtN0xODbla5nDe8Fgiaj3BwpB7FcMGmbXscXsuUpkYeQOiaaaFLsdVnec4QqrEEztWa9BGCOSyHBJQ/132, createdBy=05db2477999, createdName=124507bbm29(暂无昵称), createdTime=Mon Mar 27 00:37:33 CST 2023, time=2023-03-27, status=1, ipAttribution=北京)]
    2023-05-18 ms6000002108689902 来自甘肃省

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向：肿瘤研究;分子机制
    经验分享：投过去快三个月了，一直都是under review,唉，也是感觉编辑部的外审速度快慢不一。催稿说是外审意见还没有完全回来，只能煎熬得等待

    5

    展开5条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制<br>经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA<br>经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月 催稿不回 醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111862, encodeId=181a21118625e, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：请问最近审稿时间一般多久？投稿第二天就under review了，过了一个多月还没消息，给编辑发邮件也一周多没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Sat Jan 28 15:26:11 CST 2023, time=2023-01-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2137382, encodeId=fa7c213e382e4, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤研究;分子机制<br>经验分享：投过去快三个月了，一直都是under review,唉，也是感觉编辑部的外审速度快慢不一。催稿说是外审意见还没有完全回来，只能煎熬得等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9b6471268, createdName=ms6000002108689902, createdTime=Thu May 18 09:16:39 CST 2023, time=2023-05-18, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2089443, encodeId=bf24208944309, content=偏重的研究方向：肿瘤基础研究;肿瘤;分子机制<br>经验分享：2022.8.15 投稿； 2022.8.30返回一审意见-Major revision 两个审稿人一共提了七条意见吧大概；其中让补实验的有两条，我应该算完成了不到半条； 2022.9.13 返修； 2022.9.21 接收。 我自己这篇文章感觉其实内容还算蛮多，之前投过2个，一个小小cdd 俩星期未送外审被拒，一个cancer science 秒拒，建议转投这个杂志，投稿流程挺顺畅，审稿速度蛮快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b376540466, createdName=ms5000000426407939, createdTime=Wed Sep 21 00:07:41 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121995, encodeId=35032121995ca, content=审稿速度:1.0<br>偏重的研究方向：肿瘤基础研究;肿瘤<br>经验分享：五个figure，机制探索简单，但有回复实验。2022.12.20投稿，2023.1.12返修 major revision，给了60天。两个审稿人，每个人三个大的问题，主要是补一些数据，基本都补了。2023.3.8修回，2023.3.25接收。供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLtN0xODbla5nDe8Fgiaj3BwpB7FcMGmbXscXsuUpkYeQOiaaaFLsdVnec4QqrEEztWa9BGCOSyHBJQ/132, createdBy=05db2477999, createdName=124507bbm29(暂无昵称), createdTime=Mon Mar 27 00:37:33 CST 2023, time=2023-03-27, status=1, ipAttribution=北京)]
    2022-09-21 ms5000000426407939

    偏重的研究方向：肿瘤基础研究;肿瘤;分子机制
    经验分享：2022.8.15 投稿； 2022.8.30返回一审意见-Major revision 两个审稿人一共提了七条意见吧大概；其中让补实验的有两条，我应该算完成了不到半条； 2022.9.13 返修； 2022.9.21 接收。 我自己这篇文章感觉其实内容还算蛮多，之前投过2个，一个小小cdd 俩星期未送外审被拒，一个cancer science 秒拒，建议转投这个杂志，投稿流程挺顺畅，审稿速度蛮快

    18

    展开18条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制<br>经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA<br>经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月 催稿不回 醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111862, encodeId=181a21118625e, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：请问最近审稿时间一般多久？投稿第二天就under review了，过了一个多月还没消息，给编辑发邮件也一周多没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Sat Jan 28 15:26:11 CST 2023, time=2023-01-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2137382, encodeId=fa7c213e382e4, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤研究;分子机制<br>经验分享：投过去快三个月了，一直都是under review,唉，也是感觉编辑部的外审速度快慢不一。催稿说是外审意见还没有完全回来，只能煎熬得等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9b6471268, createdName=ms6000002108689902, createdTime=Thu May 18 09:16:39 CST 2023, time=2023-05-18, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2089443, encodeId=bf24208944309, content=偏重的研究方向：肿瘤基础研究;肿瘤;分子机制<br>经验分享：2022.8.15 投稿； 2022.8.30返回一审意见-Major revision 两个审稿人一共提了七条意见吧大概；其中让补实验的有两条，我应该算完成了不到半条； 2022.9.13 返修； 2022.9.21 接收。 我自己这篇文章感觉其实内容还算蛮多，之前投过2个，一个小小cdd 俩星期未送外审被拒，一个cancer science 秒拒，建议转投这个杂志，投稿流程挺顺畅，审稿速度蛮快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b376540466, createdName=ms5000000426407939, createdTime=Wed Sep 21 00:07:41 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121995, encodeId=35032121995ca, content=审稿速度:1.0<br>偏重的研究方向：肿瘤基础研究;肿瘤<br>经验分享：五个figure，机制探索简单，但有回复实验。2022.12.20投稿，2023.1.12返修 major revision，给了60天。两个审稿人，每个人三个大的问题，主要是补一些数据，基本都补了。2023.3.8修回，2023.3.25接收。供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLtN0xODbla5nDe8Fgiaj3BwpB7FcMGmbXscXsuUpkYeQOiaaaFLsdVnec4QqrEEztWa9BGCOSyHBJQ/132, createdBy=05db2477999, createdName=124507bbm29(暂无昵称), createdTime=Mon Mar 27 00:37:33 CST 2023, time=2023-03-27, status=1, ipAttribution=北京)]
    2023-03-27 124507bbm29(暂无昵称) 来自北京

    审稿速度:1.0
    偏重的研究方向：肿瘤基础研究;肿瘤
    经验分享：五个figure，机制探索简单，但有回复实验。2022.12.20投稿，2023.1.12返修 major revision，给了60天。两个审稿人，每个人三个大的问题，主要是补一些数据，基本都补了。2023.3.8修回，2023.3.25接收。供大家参考。

    16

    展开16条回复
共153条页码: 1/16页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分